GHO Capital (Group)

https://www.ghocapital.com

Global Healthcare Opportunities, or GHO Capital Partners LLP, is a leading specialist healthcare investment advisor based in London. We apply global capabilities and perspectives to unlock high growth healthcare opportunities, targeting Pan-European and transatlantic internationalisation to build market leading businesses of strategic global value. Our proven investment track record reflects the unrivalled depth of our industry expertise and network. We partner with strong management teams to generate long-term sustainable value, improving the efficiency of healthcare delivery to enable better, faster, more accessible healthcare. *

	Start	2014-01-01 established
	Industry	private equity
	Industry 2	healthcare
	Person	Gillings, Dennis (GHO Capital 2014– Co-Founder before Quintiles Chairman + CEO)
	Person 2	Gillings, Mireille (GHO Capital 2014– Co-Founder)

	Region	London, Greater London
	Country	United Kingdom (GB)
	Street	44 Davies Street
	City	W1K 5JA London
	Tel	+44-20-3700-7440
		Address record changed: 2020-12-02

Basic data	Employees	n. a.
	Currency	EUR
	Annual sales	2,000,000,000 (assets, managed (2019) 2019-11-20)

		* Document for »About Section«: Roslin Cell Therapies Ltd. (RoslinCT). (1/11/22). "Press Release: GHO Capital Invests in RoslinCT, a Leading Cell Therapy CDMO". Edinburgh.

		Record changed: 2023-02-24

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for GHO Capital (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)